Rechercher | SPORTIVO Network

rishika_2003 Ajouter une nouvelle offre d'emploi Health
2026-03-13 10:16:02

VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology Therapies
According to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...

0 Commentaires 0 Parts 8KB Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Kumud Ajouter une nouvelle offre d'emploi Health
2026-03-27 12:55:09

Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%
According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...

0 Commentaires 0 Parts 4KB Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Kumud Ajouter une nouvelle offre d'emploi Health
2026-04-07 12:36:34

Bladder Cancer Market to Reach USD 4.1 Billion by 2031 | CAGR 6.7%
According to a newly published market research report by 24LifeSciences, global bladder cancer market was valued at USD 2.6 billion in 2024 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2031. Bladder cancer remains one of the most prevalent urological malignancies worldwide, with non-muscle invasive...

0 Commentaires 0 Parts 2KB Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Kumud Ajouter une nouvelle offre d'emploi Health
2026-04-08 12:58:09

Bone Metastasis Therapeutics Market Growth & CAGR 8.3% Forecast
According to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...

0 Commentaires 0 Parts 1KB Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Kumud Ajouter une nouvelle offre d'emploi Health
2026-04-08 13:01:29

Bone Metastasis Therapeutics Market Growth & CAGR 8.3% Forecast
According to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...

0 Commentaires 0 Parts 1KB Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
rishika_2003 Ajouter une nouvelle offre d'emploi Health
2026-03-13 09:33:39

Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma Therapies
According to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...

1

0 Commentaires 0 Parts 4KB Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Vanshika Ajouter une nouvelle offre d'emploi Health
2026-05-28 09:01:27

Epidermal Growth Factor Receptor Inhibitor Market Strategic Insights for Leading Companies
The global Epidermal Growth Factor Receptor (EGFR) inhibitor industry is witnessing substantial momentum due to the increasing prevalence of cancer, growing adoption of targeted therapies, and advancements in precision medicine. The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 Billion by 2034 from US$ 15.92 Billion in 2025. The market is estimated to...

0 Commentaires 0 Parts 125 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
rishika_2003 Ajouter une nouvelle offre d'emploi Health
2026-03-16 06:30:43

Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology Adoption
According to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...

0 Commentaires 0 Parts 3KB Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Kumud Ajouter une nouvelle offre d'emploi Health
2026-04-09 09:44:26

Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)
According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...

1

0 Commentaires 0 Parts 1KB Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Kumud Ajouter une nouvelle offre d'emploi Health
2026-04-09 09:47:12

Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)
According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...

1

0 Commentaires 0 Parts 1KB Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Vanshika Ajouter une nouvelle offre d'emploi Health
2026-06-01 11:21:37

HDAC Inhibitor Market Outlook Across Oncology and Therapeutic Applications
The global HDAC inhibitor market is gaining significant momentum as the healthcare industry continues to advance targeted therapies for cancer and other complex diseases. Histone deacetylase (HDAC) inhibitors are a class of compounds that regulate gene expression by altering chromatin structure, making them valuable in the treatment of various malignancies and epigenetic disorders. The...

0 Commentaires 0 Parts 90 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Vanshika Ajouter une nouvelle offre d'emploi Health
2026-06-03 12:08:01

Imatinib Drug Market Dynamics and Long-Term Growth Potential
The global imatinib drug market continues to play a crucial role in the oncology sector due to the widespread use of imatinib in targeted cancer therapies. As one of the pioneering tyrosine kinase inhibitors, imatinib has significantly transformed the treatment landscape for specific cancers by offering targeted therapeutic benefits. The drug remains an important treatment option in various...

0 Commentaires 0 Parts 75 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!

Plus de résultats